Beranda › Kanker Kandung Kemih › Maryland › Baltimore
Uji klinis Kanker Kandung Kemih di Baltimore, MD
24 studi untuk Kanker Kandung Kemih mencari peserta di lokasi sekitar Baltimore (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
Menerima pesertaFase 3
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Mercy Medical Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- MedStar Franklin Square Medical Center/Weinberg Cancer Institute, Baltimore
- dan 2 lainnya
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Menerima pesertaFase 2
- Johns Hopkins University, Baltimore
DK222 Study at Hopkins
Menerima pesertaFase 1
- Johns Hopkins Hospital, Baltimore
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Menerima pesertaFase 1/2
- Oncology Research Pharmacy and lnvestigational Drug Service, Baltimore
- The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
- Johns Hopkins Hospital, Baltimore
- dan 2 lainnya
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
Menerima pesertaFase 3
- Johns Hopkins University ( Site 0843), Baltimore
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Menerima pesertaFase 3
- Johns Hopkins Hospital, Baltimore
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
Menerima pesertaFase 2
- Anne Arundel Urology, Annapolis · 22 mi jauhnya
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Menerima pesertaFase 1
- Johns Hopkins Kimmel Cancer Center, Baltimore
Measuring Surgical Recovery After Radical Cystectomy
Menerima pesertaStudi observasional
- John Hopkins Medical Institutions, Baltimore
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
Menerima pesertaFase 1/2
- John Hopkins Hospital, Baltimore
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
Menerima pesertaFase 2/3
- Johns Hopkins Hospital, Baltimore
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Menerima pesertaFase 2
- The John Hopkins Hospital, Baltimore
Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
Menerima pesertaFase 2
- Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Center, Baltimore
Bladder EpiCheck Product Development Study
Menerima pesertaStudi observasional
- Chesapeake Urology Research Associates, Towson · 8 mi jauhnya
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Menerima pesertaFase 1
- Johns Hopkins - Sidney Kimmel Comprehensive Cancer Center, Baltimore
Renal Retention in High Grade Upper Tract Urothelial Cancer
Menerima pesertaFase 2
- Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Center, Baltimore
Image-Guided Gynecologic Brachytherapy
Menerima peserta
- The SKCCC at Johns Hopkins, Baltimore
Blue Light Cystoscopy With Cysview® Registry
Menerima pesertaStudi observasional
- Johns Hopkins Medicine, Baltimore
Home Intravenous Fluid Infusion After Undergoing Radical Cystectomy
Menerima peserta
- Johns Hopkins Hospital, Baltimore
- Johns Hopkins Hospital, Baltimore
Evaluating Safety and Efficacy of Prostate-sparing Radical Cystectomy
Menerima peserta
- Johns Hopkins Hospital, Baltimore
Outcomes of High-risk Non-muscle Invasive Bladder Cancer Treated With Blue Light Resection
Menerima pesertaFase 3
- Johns Hopkins University School of Medicine, Baltimore
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Menerima pesertaStudi observasional
- Massive Bio SYNERGY-AI site, Baltimore
- Massive Bio SYNERGY-AI site, Towson · 8 mi jauhnya
Gender Related Coping and Survivorship for Genitourinary Cancers
Menerima pesertaStudi observasional
- Johns Hopkins Hospital, Baltimore
Uji klinis Kanker Kandung Kemih di kota lain
- New York City, NY35 studi
- Nashville, TN31 studi
- Houston, TX31 studi
- Dallas, TX27 studi
- Washington, DC26 studi
- Boston, MA26 studi
- Los Angeles, CA24 studi
- St. Louis, MO22 studi
- Seattle, WA21 studi
- Chicago, IL21 studi
- Philadelphia, PA21 studi
- Edison, NJ21 studi
Studi lain di Baltimore
- Kanker Paru Non-Sel Kecil60 studi
- Kanker Payudara47 studi
- Kanker Prostat43 studi
- Kanker Paru40 studi
- Kanker (semua jenis)37 studi
- Kanker Pankreas31 studi
- Kanker Kolorektal31 studi
- Kanker Metastatik28 studi
- Obesitas26 studi
- Gagal Jantung24 studi
- Kanker Ovarium22 studi
- Stroke21 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.